Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Annals of allergy

• Publication date

  1987-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 3662131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

  2004cited by this paper
• Characterization of human lymphocyte subpopulations: Alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells

  1984cited by this paper
• Acute immune complex mediated glomerulonephritis in a Chinese girl with Wiskott-Aldrich syndrome variant.

  1984cited by this paper
• Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.

  1983cited by this paper
• Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses.

  1983cited by this paper
• Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study.

  1982cited by this paper
• Immunoregulatory abnormalities in mucocutaneous lymph node syndrome.

  1982cited by this paper
• Possible role for mite antigen In Kawasaki disease.

  1981cited by this paper
• Acute febrile mucocutaneous lymph node syndrome.

  1980cited by this paper
• The Raji cell radioimmune assay for detecting immune complexes in human sera.

  1976cited by this paper
• Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.

  1975cited by this paper
• A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

  1974cited by this paper

• The Role of Circulating Immune Complexes in Coronary Artery Lesions: Understanding possible Patho-Physiology in Kawasaki Disease Revisited

  2022cites this paper
• Hyperinflammatory Syndrome in Children Related to Covid-19

  2021cites this paper
• Could Immunoglobulin Level Be a Prognostic Factor for Coronary Artery Lesions in Kawasaki Diseases?

  2021cites this paper
• Hygiene Hypothesis as the Etiology of Kawasaki Disease: Dysregulation of Early B Cell Development

  2021cites this paper
• Kawasaki Disease: The Role of Immune Complexes Revisited

  2019cites this paper
• Variation in IL-21-secreting circulating follicular helper T cells in Kawasaki disease

  2018cites this paper
• Occupational and Environmental Skin Disorders

  2018cites this paper
• Serum complement levels in anti‐N‐methyl‐d‐aspartate receptor encephalitis

  2018cites this paper
• Overview on Other Environmental Skin Disorders

  2018cites this paper
• Correlation between elevated platelet count and immunoglobulin levels in the early convalescent stage of Kawasaki disease

  2017cites this paper
• Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease: a meta-analysis.

  2015cites this paper
• Association between the FCGR 2 A gene H 131 R polymorphism and risk of Kawasaki disease : a meta-analysis

  2015cites this paper
• Histopathological evaluation of horse serum-induced immune complex vasculitis in swine: implication to coronary artery lesions in Kawasaki disease.

  2014cites this paper
• Acute-Phase Reactants and a Supplemental Diagnostic Aid for Kawasaki Disease

  2010cites this paper
• A systematic review and meta‐analysis of tumor necrosis factor α‐308 polymorphism and Kawasaki disease

  2010cites this paper
• Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.

  2010influential citation
• Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody

  2009cites this paper
• Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India

  2006cites this paper
• The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease

  2005cites this paper
• Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease

  2005cites this paper
• Advances in Kawasaki disease

  2004cites this paper
• Chemokines in Kawasaki disease: measurement of CCL2, CCL22 and CXCL10.

  2003cites this paper
• Increased production of serum IgA‐class antibody to lipid A in Kawasaki disease

  2002cites this paper
• Surface and Cytoplasmic Immunoglobulin Expression in Circulating B-Lymphocytes in Acute Kawasaki Disease

  2001cites this paper
• Increased Frequency of Alleles Associated with Elevated Tumor Necrosis Factor-α Levels in Children with Kawasaki Disease

  2001cites this paper
• Kawasaki syndrome.

  1999cites this paper
• Kawasaki Syndrome

  1998cites this paper
• Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease.

  1997cites this paper
• IgA plasma cells in vascular tissue of patients with Kawasaki syndrome.

  1997cites this paper
• Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease.

  1997cites this paper
• Adult Kawasaki Disease: Report of Two Cases Treated With Intravenous Gamma Globulin

  1994cites this paper
• Classical pathway complement activation in Kawasaki syndrome.

  1994cites this paper
• Immunologic abnormalities in children with acute Kawasaki disease.

  1993cites this paper
• Cytokines predict coronary aneurysm formation in Kawasaki disease patients

  1993cites this paper
• Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.

  1992cites this paper
• Virus‐like particles with reverse transcriptase activity associated with kawasaki disease

  1992cites this paper
• Antioxidant Enzymes and Lipoperoxide in Blood in Patients with Kawasaki Disease Comparison with the Changes in Acute Infections

  1990cites this paper
• In vitro B-lymphocyte switch disturbance from IgM into IgG in IgM mesangial nephropathy

  1989cites this paper
• High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses.

  1989cites this paper